Read More Biotech Events General News Celldex Announces Upcoming Presentation Of Barzolvolimab Phase 2 Results In Chronic Spontaneous Urticaria At AAAAI 2024 By Benzinga Newsdesk February 5, 9:12 AM Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing 12 week results from the Company's Phase 2 clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneous CLDX
Read More Cannabis General Markets Politics ‘On Marijuana Banking Bill, Congressman Is Balancing Optimism With Realism As Senate Talks Heat Up’ -Marijuana Moment Report By Benzinga Newsdesk November 30, 12:54 PM https://www.marijuanamoment.net/on-marijuana-banking-bill-congressman-is-balancing-optimism-with-realism-as-senate-talks-heat-up/ ACB
Read More Education General Legal News Tech Top Stories Elon Musk Tweets ‘Funding Secured’ In 2018: How Much Would $1,000 In Tesla Stock Be Worth Now? By Chris Katje January 26, 2:40 PM A controversial tweet by Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is now the subject of a lawsuit. GOOG
Read More Analyst Color Analyst Ratings Equities General Markets News Reiteration Trading Ideas From Growth Targets To Headcount Cuts, Analyst Reviews Snap’s Roadmap To 2024 By Nabaparna Bhattacharya October 17, 1:40 PM Benchmark analyst Mark Zgutowicz SNAP